Schizophrenia Research Today is a free monthly online journal that collates and summarizes the latest research about Schizophrenia, including details on paranoia, symptoms, treatment, depression, medication.

Volume 4 (2007), Issue 5 (May)

1. Cerebellar volumes in men with schizophrenia and alcohol dependence.
   Psychiatry Clin Neurosci, 61(3): 326-9. [Abstract] [Full-text]
2. The role of selegiline in the treatment of negative symptoms associated with schizophrenia.
   Ann Pharmacother, 41(5): 851-6. [Abstract] [Full-text]
3. Subjective and physiological responses to emotion-eliciting pictures in male schizophrenic patients.
   Int J Psychophysiol, 64(2): 174-83. [Abstract] [Full-text]
4. Genetic structure of the dopamine receptor D4 gene (DRD4) and lack of association with schizophrenia in Japanese patients.
   J Psychiatr Res, 41(9): 763-75. [Abstract] [Full-text]
5. Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia.
   Am J Psychiatry, 164(5): 813-9. [Abstract] [Full-text]
6. Substantial shared genetic influences on schizophrenia and event-related potentials.
   Am J Psychiatry, 164(5): 804-12. [Abstract] [Full-text]
7. Characteristics of social perception assessed in schizophrenia using virtual reality.
   Cyberpsychol Behav, 10(2): 215-9. [Abstract] [Full-text]
8. Apathy syndrome after traumatic brain injury compared with deficits in schizophrenia.
   Psychosomatics, 48(3): 217-22. [Abstract] [Full-text]
9. What is a schizophrenic mouse?
   Neuron, 54(3): 348-9. [Abstract] [Full-text]
10. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia.
    Arch Gen Psychiatry, 64(5): 532-42. [Abstract] [Full-text]
11. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia.
    Arch Gen Psychiatry, 64(5): 521-9. [Abstract] [Full-text]
12. Neuroleptic withdrawal with remitted schizophrenics: a naturalistic follow-up study.
    Psychiatry, 70(1): 68-79. [Abstract] [Full-text]
13. Distal support and community living among individuals diagnosed with schizophrenia and schizoaffective disorder.
    Psychiatry, 70(1): 1-11. [Abstract] [Full-text]
14. Association study between the transferrin gene and schizophrenia in the Japanese population.
    Neuroreport, 18(5): 517-20. [Abstract] [Full-text]
15. Longitudinal changes in neuroanatomy and neural activity in early schizophrenia.
    Neuroreport, 18(5): 435-9. [Abstract] [Full-text]
16. Disturbed frontal gyrification within families affected with schizophrenia.
    J Psychiatr Res, 41(10): 805-13. [Abstract] [Full-text]
17. M129V variation in the prion protein gene and psychotic disorders: relationship to neuropsychological and psychopathological measures.
    J Psychiatr Res, 41(10): 885-92. [Abstract] [Full-text]
18. Normal personality characteristics in schizophrenia: a review of the literature involving the FFM.
    J Nerv Ment Dis, 195(5): 421-9. [Abstract] [Full-text]
19. Neurocognitive deterioration in elderly chronic schizophrenia patients with and without PTSD.
    J Nerv Ment Dis, 195(5): 415-20. [Abstract] [Full-text]
20. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study.
    J Nerv Ment Dis, 195(5): 406-14. [Abstract] [Full-text]
21. Gender differences in young adults with first-episode schizophrenia spectrum disorders at baseline in the Danish OPUS study.
    J Nerv Ment Dis, 195(5): 396-405. [Abstract] [Full-text]
22. Neuroleptic treatment effect on mitochondrial electron transport chain: peripheral blood mononuclear cells analysis in psychotic patients.
    J Clin Psychopharmacol, 27(3): 284-8. [Abstract] [Full-text]
23. All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics: an integrated analysis.
    J Clin Psychopharmacol, 27(3): 252-8. [Abstract] [Full-text]
24. Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population.
    J Clin Psychopharmacol, 27(3): 246-51. [Abstract] [Full-text]
25. Association study between Apolipoprotein L and schizophrenia by exhaustive and rule-based combination analysis for identification of multilocus interactions.
    J Biosci Bioeng, 103(4): 303-10. [Abstract] [Full-text]
26. Is dietary pattern of schizophrenia patients different from healthy subjects?
    BMC Psychiatry, 7: 15. [Abstract] [Full-text]
27. Metabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study.
    BMC Psychiatry, 7: 14. [Abstract] [Full-text]
28. Association of the dopamine receptor interacting protein gene, NEF3, with early response to antipsychotic medication.
    Int J Neuropsychopharmacol, 10(3): 321-33. [Abstract] [Full-text]
29. Circulatory neurosteroid levels in smoking and non-smoking chronic schizophrenia patients.
    Eur Neuropsychopharmacol, 17(8): 541-5. [Abstract] [Full-text]
30. COMT val158Met and executive control: a test of the benefit of specific deficits to translational research.
    J Abnorm Psychol, 116(2): 306-12. [Abstract] [Full-text]
31. Cognitive processing of facial affect: connectionist model of deviations in schizophrenia.
    J Abnorm Psychol, 116(2): 290-305. [Abstract] [Full-text]
32. Verbal communication impairments and cognitive control components in people with schizophrenia.
    J Abnorm Psychol, 116(2): 279-89. [Abstract] [Full-text]
33. Patients with schizophrenia demonstrate dissociation between affective experience and motivated behavior.
    J Abnorm Psychol, 116(2): 268-78. [Abstract] [Full-text]
34. Movement abnormalities and the progression of prodromal symptomatology in adolescents at risk for psychotic disorders.
    J Abnorm Psychol, 116(2): 260-7. [Abstract] [Full-text]
35. Clozapine-resistant psychosis, smoking, and caffeine: managing the neglected effects of substances that our patients consume every day.
    Am J Ther, 14(3): 314-8. [Abstract] [Full-text]
36. The perceived burden among Chinese family caregivers of people with schizophrenia.
    J Clin Nurs, 16(6): 1151-61. [Abstract] [Full-text]
37. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
    Mol Pharmacol, 71(6): 1598-609. [Abstract] [Full-text]
38. Similar frequency of abnormal correlation between serum leptin levels and BMI before and after olanzapine treatment in schizophrenia.
    Int Clin Psychopharmacol, 22(4): 205-11. [Abstract] [Full-text]
39. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Int Clin Psychopharmacol, 22(4): 192-6. [Abstract] [Full-text]
40. Health-related quality of life of Chinese people with schizophrenia in Hong Kong and Taipei: a cross-sectional analysis.
    Res Nurs Health, 30(3): 261-9. [Abstract] [Full-text]
41. Gap junction coding genes and schizophrenia: a genetic association study.
    J Hum Genet, 52(6): 498-501. [Abstract] [Full-text]
42. The latent structure and coincidence of hypohedonia and schizotypy and their validity as indices of psychometric risk for schizophrenia.
    J Personal Disord, 21(3): 225-42. [Abstract] [Full-text]

© 2004-2010 Schizophrenia Research Today. All Rights Reserved.